Upregulation of vascular angiotensin II receptor gene expression by low- density lipoprotein in vascular smooth muscle cells

Circulation

Volumn 95, Issue 2, 1997, Pages 473-478

  Nickenig, G ^b   Sachinidis, A ^c   Michaelsen, F ^c   Bohm M ^a,b   Seewald, S ^c   Vetter, H ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Med Universitäts Poliklinik ^*

Author keywords

angiotensin; arteriosclerosis; genes; hypertension; lipoproteins

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ANGIOTENSIN 1 RECEPTOR; LOW DENSITY LIPOPROTEIN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; HYPERTENSION; LIPID PEROXIDATION; MOLECULAR INTERACTION; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

EID: 0031023734     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.2.473     Document Type: Article

References (5)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res. 1986;58:427-444.
3. Jackson CL, Schwartz SM. Pharmacology of smooth muscle cell replication. Hypertension. 1992;20:713-736.
4. Bobik A, Campbell JH. Vascular-derived growth factors: cell biology, pathophysiology and pharmacology. Phannacol Rev. 1993;45:l-42.
5. Kannel WB, Gordon T, Castelli P. Role of lipids and lipoprotein fractions in assessing atherogenesis. the Framingham study. Prog Lipid Res. 1981;20:339-348.